• Latest Posts

New Replay HSV gene therapy company Telaria to focus on skin diseases

TrialSpark acquires immunodermatology portfolio and creates Libertas Bio

Incyte to acquire Medicxi-backed Villaris Therapeutics to tackle vitiligo

Arcutis Biotherapeutics acquires Ducentis BioTherapeutics in deal worth up to $400M

In Depth 3 Mar 2023

Let’s Take a Closer Look at 7 Autoimmune Diseases Biotechs are Fighting to Treat

ADVERTISEMENT

Latest advancements in psoriasis research over the past year

Breakthrough treatment for skin infections?

Intracellular “smoke detector” discovery has skin disease therapy implications

Janssen’s Psoriasis Drug is Given a Thumbs Up for Use in Europe

New Psoriasis Antibody Therapy puts pressure on Best-Seller drug Humira

ADVERTISEMENT